|Articles|March 15, 2002
- BioPharm International-03-15-2002
- Volume 15
- Issue 3
Outsourcing Outlook: Using Earned-Value Analysis for Better Project Management
Author(s)Jim Miller, Heather B. Hayes
by Heather B Hayes, a freelance writer, and Jim Miller, publisher of the Bio/Pharmaceutical Outsourcing Report EVA allows project managers to refer to tangible numbers, not just a gut feeling, in determining whether a project is advancing on time and within budget.
Advertisement
Articles in this issue
almost 24 years ago
Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?almost 24 years ago
Guest Editorial: Warning Letters ? A Symptom?almost 24 years ago
The Importance of Freezing on Lyophilization Cycle Developmentalmost 24 years ago
Business Benefits of Computer Systems Validationalmost 24 years ago
A System Developer's Approach to ValidationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
2
China Approves First Monthly Biologic for COPD
3
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
4
FUJIFILM Irvine Scientific Rebrands as FUJIFILM Biosciences
5
